Pulmonary Rehabilitation in patients with COPD: Effects on Cognitive Performance, Mood, Anxiety, and Quality of Life.

Pulmonary Rehabilitation in patients with COPD: Effects on Cognitive Performance, Mood, Anxiety, and Quality of Life. - effects on cognition in patients with COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34268

Enrollment

312

Registered

2010-11-10

Start date

2011-01-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

A multidisciplinary, fulltime Extensive Pulmonary rehabilitation Program with a duration of 12 weeks, developed at Schoondonck - Centre for pulmonary Rehabilitation according to the current guidelin

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diagnosis COPD reference to Extensive Pulmonary Rehabilitation at Schoondonck

Exclusion criteria

Exclusion criteria: Education level lower than II (=unfinished to the coding system of Verhage (1983) Reference to the Compact Pulmonary rehabilitation Program at Schoondonck.

Design outcomes

Primary

Measure	Time frame
The difference between the experimental group and the waiting list control group on the change of cognitive performance, QoL, mood, and anxiety between baseline measurement (both groups) and second moment of measurement, either before treatment (waiting list control group) or after treatment (experimental group). Cognitive functioning is measured with objective neuropsychological tests and a self report questionnaire for subjective cognitive functioning. Mood, anxiety, and QoL are measured with self report questionnaires.	—

Measure

Time frame

The difference between the experimental group and the waiting list control group on the change of cognitive performance, QoL, mood, and anxiety between baseline measurement (both groups) and second moment of measurement, either before treatment (waiting list control group) or after treatment (experimental group). Cognitive functioning is measured with objective neuropsychological tests and a self report questionnaire for subjective cognitive functioning. Mood, anxiety, and QoL are measured with self report questionnaires.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)